JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vegt, E.
Right arrow Articles by Oyen, W. J.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vegt, E.
Right arrow Articles by Oyen, W. J.G.

Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin

Erik Vegt, MD1, Jack F.M. Wetzels, MD, PhD2, Frans G.M. Russel, PhD3, Rosalinde Masereeuw, PhD3, Otto C. Boerman, PhD1, Juliette E. van Eerd, PhD1, Frans H.M. Corstens, MD, PhD1 and Wim J.G. Oyen, MD, PhD1

1 Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 2 Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and 3 Department of Pharmacology and Toxicology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands


Figure 1
View larger version (13K):

[in a new window]
 
FIGURE 1.  %ID (mean ± SD) of 111In-OCT over time in kidneys at baseline or after infusion of GELO. Significantly less 111In-OCT was retained in kidneys after GELO infusion than after normal saline infusion (P = 0.006 for difference in areas under curves).

 

Figure 2
View larger version (12K):

[in a new window]
 
FIGURE 2.  %ID (mean ± SD) of 111In-OCT over time in kidneys at baseline or after infusion of HES. No statistically significant difference was observed between infusion of normal saline and infusion of HES.

 

Figure 3
View larger version (125K):

[in a new window]
 
FIGURE 3.  Posterior images of kidney region 24 h after injection of 111In-OCT at baseline (A) and after GELO infusion (B) and at baseline (C) and after HES infusion (D). GELO resulted in renal uptake levels lower than those at baseline, whereas HES had no effect.

 

Figure 4
View larger version (16K):

[in a new window]
 
FIGURE 4.  Clearance of 111In-OCT from blood over time. No statistically significant differences were observed between groups.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.